|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cardiac Imaging |
1 From the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, Box 1030, One Gustave L. Levy Place, New York, NY 10029 (J.S., P.K., R. Salguero, R. Sulica, A.J.E., S.D., V.F., S.R.); Department of Cardiology, Centro Médico Teknon, Barcelona, Spain (T.R.); and Department of Cardiology, Cabrini Medical Center, New York, NY (M.P.). Received March 15, 2006; revision requested May 18; revision received June 13; final version accepted August 9. Supported in part by the Mount Sinai School of Medicine Consortium for Cardiovascular Imaging Technology, New York, NY. J.S. supported by a research grant from the Spanish Society of Cardiology ("Beca para la Formación en Investigación Post-Residencia"). S.D. supported by a research grant from the Italian Society of Cardiology. Address correspondence to J.S. (email: Javier.Sanz@mssm.edu).
Purpose: To retrospectively identify pulmonary arterial (PA) flow parameters measured with phase-contrast magnetic resonance (MR) imaging that allow noninvasive diagnosis of chronic PA hypertension (PAH).
Materials and Methods: The study was HIPAA compliant and was approved by the institutional review board; a waiver of informed consent was obtained. Fifty-nine patients (49 female patients; mean age, 46 years; range, 1685 years) known to have or suspected of having PAH underwent breath-hold phase-contrast MR imaging and right-sided heart catheterization (RHC). The presence of PAH (mean pulmonary artery pressure [mPAP], >25 mm Hg) was confirmed in 42 patients. Parameters, including PA areas, PA strain, average velocity, peak velocity, acceleration time, and ejection time, were measured in each patient by investigators blinded to RHC results. These measurements were correlated with mPAP, systolic pulmonary artery pressure (sPAP), and pulmonary vascular resistance index (PVRI). The diagnostic ability of phase-contrast MR imaging to depict PAH was quantified. Statistical tests included Spearman
coefficients, receiver operating characteristic curve analysis, and Bland-Altman plots.
Results: Results showed average velocity to have the best correlation with mPAP, sPAP, and PVRI (r = 0.73, 0.76, and 0.86, respectively; P < .001). Average velocity (cutoff value = 11.7 cm/sec) revealed PAH with a sensitivity of 92.9% (39 of 42) and a specificity of 82.4% (14 of 17). Sensitivity and specificity for the minimum PA area (cutoff value = 6.6 cm2) were 92.9% (39 of 42) and 88.2% (15 of 17), respectively.
Conclusion: The average blood velocity throughout the cardiac cycle is strongly correlated with pulmonary pressures and resistance.
© RSNA, 2007
This article has been cited by other articles:
![]() |
J. Sanz, M. Kariisa, S. Dellegrottaglie, S. Prat-Gonzalez, M. J. Garcia, V. Fuster, and S. Rajagopalan Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 286 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Benza, R. Biederman, S. Murali, and H. Gupta Role of Cardiac Magnetic Resonance Imaging in the Management of Patients With Pulmonary Arterial Hypertension J. Am. Coll. Cardiol., November 18, 2008; 52(21): 1683 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyazaki and V. S. Lee Nonenhanced MR Angiography Radiology, July 1, 2008; 248(1): 20 - 43. [Abstract] [Full Text] [PDF] |
||||